AstraZeneca's market value has surpassed £ 200 billion for the first time! The bold bet on anti-cancer drugs is yielding results
王俊杰2017
发表于 2024-8-14 19:22:12
188
0
0
The market value of global pharmaceutical giant AstraZeneca broke through £ 200 billion ($257 billion) for the first time yesterday, after the company's bold bets on cancer drugs drove its stock price up continuously.
On Tuesday (August 13th), the company's market value exceeded £ 200 billion for the first time; After the opening of the London session on Wednesday, the stock rose by 0.5% at one point, expanding its gains since the beginning of the year to 22%, and then experienced a slight correction.
Currently, AstraZeneca is the most valuable listed company in the UK, leading Shell since April this year. In US dollar terms, AstraZeneca's market value ranks seventh in Europe.
Since 2012, Pascal Sooriot, the CEO of AstraZeneca, has been leading the company. Two years after he took office, American pharmaceutical company Pfizer abandoned its acquisition of AstraZeneca, which boosted AstraZeneca's stock price. As a result, Sooriot received praise and solidified its position.
In recent years, AstraZeneca has made significant investments in anti-cancer drugs, which have proven to be successful. By 2023, Sooriot's bet on anti-cancer drugs will bring AstraZeneca's annual revenue to over $45 billion and set a target of $80 billion in sales for the company by 2030.
In June this year, an experimental study showed that AstraZeneca's lung cancer and breast cancer drugs significantly slowed the spread of the disease in the two trials. Positive experimental data showed that these drugs might become a new treatment scheme for some patients.
Danni Hewson, the head of financial analysis at AJ Bell, said, "The company's growth has been stable rather than volatile, and its potential for progress in cancer treatment and certain weight loss drugs has attracted investors' attention. This is also a blessing for the London market
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Eisai/Bojian Alzheimer's disease drug rejected by the European Union, and Eli Lilly monoclonal antibody may be affected
- Bristol Myers Squibb's original tumor treatment drug Abraxane has been officially launched in China
- The iPhone 16 will ignite a wave of phone swapping! Wedbush: Apple's market value is expected to reach $4 trillion next year
- soar! The market value of "Seven sisters" has soared by 7 trillion yuan! AI chip giant gains over 22% this week, surpassing Tesla in market value
- Striving for the top spot in the world! NVIDIA's market value reaches a historic high of $3.39 trillion: Blackwell is sold out in the next year
- BlackRock Bitcoin ETF's market value exceeds $25 billion
- Top 20 US Stock Exchange Transactions: TSMC Increases Over 9%, Market Value Exceeds $1 Trillion
- Stock Market Special Report | TSMC's Market Value Exceeds $1 Trillion, Becoming the First Chinese Concept Stock Company to Achieve a Market Value of Over $1 Trillion
- TSMC's market value exceeds $1 trillion! Annual revenue expected to increase by 30%: AI demand is crazy and just beginning
- Nvidia's intraday market value surpasses Apple again, and the battle for the top spot in the US stock market is becoming increasingly fierce
-
随着“银十”结束,各家造车新势力都交出了一份亮眼的成绩单。 理想领跑10月新势力交付榜,鸿蒙智行重回4万辆,零跑、深蓝、极氪、小鹏等单月交付量均创新高,岚图、阿维塔、智己等实现破万,但哪吒却消失在 ...
- fanadam
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
何思文表示,“在进博会这个平台上,我们开启的是倾听模式,通过进博会展出各类产品,收集消费者的需求和反馈,进而帮助决定未来进口到中国的产品。过去,汽车行业的许多创新源于美国加州或欧洲。我相信,中国正 ...
- MaxLucky
- 5 小时前
- 支持
- 反对
- 回复
- 收藏
-
11月5日至10日,第七届中国国际进口博览会(下称“进博会”)在国家会展中心(上海)举办。在进博会期间,平安健康医疗科技有限公司(下称“平安健康”)与美敦力(上海)管理有限公司(下称“美敦力”)达成战 ...
- Hidden2
- 前天 17:06
- 支持
- 反对
- 回复
- 收藏
-
今年上半年业绩表现低迷的百胜中国在第三季度打了个“翻身仗”。11月4日,百胜中国发布三季报显示,今年第三季度,其净利润同比增长22%。而在第一季度、第二季度,该公司净利润增长率分别为-1%、8%,第三季度净 ...
- nihaosifa
- 前天 15:35
- 支持
- 反对
- 回复
- 收藏